22 Hrs
Source:
Los Angeles Times
Plant extract potential in opioid treatment
The article reports that the National Institutes of Health and researchers from the University of Florida are beginning clinical trials on mitragynine, the main psychoactive compound in kratom, to assess its potential for treating opioid use disorder. Despite concerns over kratom’s safety, especially regarding its potent component 7-hydroxymitragynine (7-OH) associated with overdose deaths, researchers see promise in further studying the plant’s therapeutic effects. Public health officials and regulators are increasingly scrutinizing kratom, with California taking legal actions against producers and seizing products due to health risks, while ongoing research aims to explore its potential as an alternative treatment option.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)